Humana’s outlook isn’t great, but performance in the fourth quarter was a bit better than expected. Despite the beat, however ...

The dip came after Humana released its 2024 end of year and fourth quarter earnings, which projected an annual profit of ...

Humana Inc.’s stock fell 5.6% Tuesday, after the health insurer and managed-care company’s quarterly loss widened. The ...

Barclays analyst Andrew Mok raised the firm’s price target on Humana (HUM) to $270 from $255 and keeps an Equal Weight rating on the shares.

Humana will make investments to improve its Medicare Advantage Star Ratings, Chief Financial Officer Celeste Mellet said.

RBC Capital analyst Ben Hendrix maintained a Buy rating on Humana (HUM – Research Report) yesterday and set a price target of $283.00. The ...

Humana posted a $693 million loss in the fourth quarter of 2024, a notable increase from its $541 million loss in the ...

Humana maintains a healthy balance sheet, in our opinion. Most of its cash and investments ($24 billion as of mid-2024) is held at its subsidiaries, though, and the company aims to hold about $500 ...

The massive insurer now expects to lose 550,000 Medicare Advantage members — roughly one-tenth its individual MA footprint — ...

Humana's CEO, James Rechtin, emphasized that 2024 adjusted EPS met initial guidance, including investments in Stars and growth, and reaffirmed the 2025 outlook with a continued focus on achieving a 3% ...

Greater Louisville Inc. unveiled its new five-year strategic plan, Prosper 2030, which focuses on job creation, population ...

Humana executives said the tower will likely remain occupied until the end of the year as employees transition to the new space.